Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Review ArticleReview

Immunology and immunotherapy in breast cancer

Vladimir Semiglazov, Andrey Tseluiko, Asel Kudaybergenova, Anna Artemyeva, Petr Krivorotko and Roman Donskih
Cancer Biology & Medicine May 2022, 19 (5) 609-618; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0597
Vladimir Semiglazov
1Petrov National Medicine Cancer-Research Center Ministry of Health, Saint-Petersburg 197758, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vsemiglazov{at}mail.ru
Andrey Tseluiko
1Petrov National Medicine Cancer-Research Center Ministry of Health, Saint-Petersburg 197758, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asel Kudaybergenova
1Petrov National Medicine Cancer-Research Center Ministry of Health, Saint-Petersburg 197758, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Artemyeva
1Petrov National Medicine Cancer-Research Center Ministry of Health, Saint-Petersburg 197758, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petr Krivorotko
1Petrov National Medicine Cancer-Research Center Ministry of Health, Saint-Petersburg 197758, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roman Donskih
1Petrov National Medicine Cancer-Research Center Ministry of Health, Saint-Petersburg 197758, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 19 no. 5 609-618
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2021.0597
PubMed 
35676750

Published By 
Cancer Biology & Medicine
History 
  • Received December 16, 2021
  • Accepted March 7, 2022
  • Published online June 24, 2022.

Copyright & Usage 
Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Vladimir Semiglazov1⇑,
  2. Andrey Tseluiko1,
  3. Asel Kudaybergenova1,
  4. Anna Artemyeva1,
  5. Petr Krivorotko1 and
  6. Roman Donskih1
  1. 1Petrov National Medicine Cancer-Research Center Ministry of Health, Saint-Petersburg 197758, Russia
  1. Correspondence to: V. F. Semiglazov, E-mail: vsemiglazov{at}mail.ru
View Full Text

Cited By...

  • 28 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 19 (5)
Cancer Biology & Medicine
Vol. 19, Issue 5
15 May 2022
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Immunology and immunotherapy in breast cancer
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Immunology and immunotherapy in breast cancer
Vladimir Semiglazov, Andrey Tseluiko, Asel Kudaybergenova, Anna Artemyeva, Petr Krivorotko, Roman Donskih
Cancer Biology & Medicine May 2022, 19 (5) 609-618; DOI: 10.20892/j.issn.2095-3941.2021.0597

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Immunology and immunotherapy in breast cancer
Vladimir Semiglazov, Andrey Tseluiko, Asel Kudaybergenova, Anna Artemyeva, Petr Krivorotko, Roman Donskih
Cancer Biology & Medicine May 2022, 19 (5) 609-618; DOI: 10.20892/j.issn.2095-3941.2021.0597
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Immunosurveillance of BC
    • TILs in BC subtypes
    • Peritumoral and intratumoral FOXP3+ Tregs in patients with BC
    • Immunotherapy of advanced and metastatic TNBC
    • Role of immunotherapy in early TNBC
    • New combinatorial strategy
    • Safety
    • Conclusions
    • Conflict of interest statement
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Targeting the novel immune checkpoint KLRG1 is markedly therapeutic against cancer through multiple lymphocyte subsets
  • Hypoxia upregulates the expression of PD-L1 via NPM1 in breast cancer
  • Decreased LDHB expression in breast tumor cells causes NK cell activation and promotes tumor progression
  • Cutting the root: the next generation of T cells engagers against cancer stem cells to overcome drug resistance in triple-negative breast cancer
  • Cancer cells communicate with macrophages to prevent T cell activation during development of cell cycle therapy resistance
  • Google Scholar

More in this TOC Section

  • Global epidemiology of ovarian cancer: patterns, trends, and risk factors
  • Harnessing the microbiome: a new frontier in lung cancer immunotherapy
  • Next-generation CAR immunotherapy for neuroblastoma: expanding the role of immune cell platforms
Show more Review

Similar Articles

Keywords

  • Breast cancer
  • Tumor-infiltrating lymphocytes
  • PD-1
  • PD-L1
  • immunotherapy

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire